Portal de Periódicos da CAPES

The purinergic component of human vas deferens contraction

2006; Elsevier BV; Volume: 85; Issue: 4 Linguagem: Inglês

10.1016/j.fertnstert.2005.09.024

1556-5653

Frederick Banks, Gillian E. Knight, Robert C. Calvert, Cecil S. Thompson, Robert J. Morgan, Geoffrey Burnstock,

Pregnancy and Medication Impact

To examine purinergic signaling in human vas deferens.To study contractile responses of the scrotal vas deferens.Research department of a university teaching hospital.Undergoing vasectomy or orchidectomy (aged 27-88 years, n = 14).Vasectomy or orchidectomy.Strips of vas deferens were suspended in an organ bath and subjected to electrical stimulation to establish frequency-response curves. These stimulations were repeated in the presence of pyridoxalphosphate-6-azophenyl-2',4'-disulfonic acid (PPADS, P2 receptor antagonist), prazosin (adrenergic alpha1 antagonist), and tetrodotoxin. Concentration-response curves were constructed to noradrenaline and the P2X agonists ATP and alpha,beta-methylene ATP (alpha,beta-meATP). The P2X receptor subtype distribution was assessed by immunohistochemistry using specific antibodies.The response at 32 Hz in the presence of PPADS was reduced by 40% and in the presence of prazosin by 80%. Noradrenaline caused concentration-dependent contractions (EC50 = 11.8 microM). Contractions to ATP and alpha,beta-meATP (EC50 = 6.27 microM) suggested that the functional receptor was P2X1 and/or P2X3. However, immunohistochemistry demonstrated P2X1, but not P2X3, receptor immunoreactivity on the smooth muscle cells.This study demonstrated that ATP is a co-transmitter with noradrenaline in the contraction of the human vas deferens predominantly acting through the P2X1 receptor.